Cargando…

Comparison of prognostic gene expression signatures for breast cancer

BACKGROUND: During the last years, several groups have identified prognostic gene expression signatures with apparently similar performances. However, signatures were never compared on an independent population of untreated breast cancer patients, where risk assessment was computed using the origina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haibe-Kains, Benjamin, Desmedt, Christine, Piette, Fanny, Buyse, Marc, Cardoso, Fatima, van't Veer, Laura, Piccart, Martine, Bontempi, Gianluca, Sotiriou, Christos
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533026/ https://www.ncbi.nlm.nih.gov/pubmed/18717985 http://dx.doi.org/10.1186/1471-2164-9-394

Ejemplares similares

A fuzzy gene expression-based computational approach improves breast cancer prognostication
por: Haibe-Kains, Benjamin, et al.
Publicado: (2010)

Multiple-input multiple-output causal strategies for gene selection
por: Bontempi, Gianluca, et al.
Publicado: (2011)

A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?
por: Haibe-Kains, B., et al.
Publicado: (2008)

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
por: Wirapati, Pratyaksha, et al.
Publicado: (2008)

Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues
por: Toussaint, Jérôme, et al.
Publicado: (2009)

Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology
por: Fumagalli, Debora, et al.
Publicado: (2014)

Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer
por: Rothé, Françoise, et al.
Publicado: (2011)

The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1–98 trial
por: Desmedt, Christine, et al.
Publicado: (2009)

Late effects of adjuvant chemotherapy adumbrate dormancy complexity in breast cancer
por: Demicheli, Romano, et al.
Publicado: (2020)

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
por: Loi, Sherene, et al.
Publicado: (2008)

Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer
por: Loi, Sherene, et al.
Publicado: (2009)

Relevance of different prior knowledge sources for inferring gene interaction networks
por: Olsen, Catharina, et al.
Publicado: (2014)

Low CD10 mRNA Expression Identifies High-Risk Ductal Carcinoma In Situ (DCIS)
por: Toussaint, Jérôme, et al.
Publicado: (2010)

Gene expression profiling in breast cancer challenges the existence of intermediate histological grade
por: Sotiriou, C, et al.
Publicado: (2005)

Study of Meta-analysis strategies for network inference using information-theoretic approaches
por: Pham, Ngoc C., et al.
Publicado: (2017)

Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations
por: Nguyen, Bastien, et al.
Publicado: (2018)

Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients
por: Haibe-Kains, B., et al.
Publicado: (2013)

Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response
por: Li, Qiyuan, et al.
Publicado: (2011)

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
por: Li, Yang, et al.
Publicado: (2010)

Predictive networks: a flexible, open source, web application for integration and analysis of human gene networks
por: Haibe-Kains, Benjamin, et al.
Publicado: (2012)

Significance Analysis of Prognostic Signatures
por: Beck, Andrew H., et al.
Publicado: (2013)

Association between SPARC mRNA Expression, Prognosis and Response to Neoadjuvant Chemotherapy in Early Breast Cancer: A Pooled in-silico Analysis
por: Azim, Hatem A., et al.
Publicado: (2013)

Correction: Association between SPARC mRNA Expression, Prognosis and Response to Neoadjuvant Chemotherapy in Early Breast Cancer: A Pooled in-silico Analysis
por: Azim, Hatem A., et al.
Publicado: (2013)

Using shRNA experiments to validate gene regulatory networks
por: Olsen, Catharina, et al.
Publicado: (2015)

DNA methylation profiling reveals a predominant immune component in breast cancers
por: Dedeurwaerder, Sarah, et al.
Publicado: (2011)

Radiomic feature clusters and Prognostic Signatures specific for Lung and Head & Neck cancer
por: Parmar, Chintan, et al.
Publicado: (2015)

Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer
por: Sonnenblick, Amir, et al.
Publicado: (2015)

Clinico-pathological and transcriptomic determinants of SLFN11 expression in invasive breast carcinoma
por: Zoppoli, Gabriele, et al.
Publicado: (2015)

Quantitative assessment and validation of network inference methods in bioinformatics
por: Haibe-Kains, Benjamin, et al.
Publicado: (2014)

DNA replication stress: a source of APOBEC3B expression in breast cancer
por: Cescon, David W., et al.
Publicado: (2016)

Gene Expression Analyses in Breast Cancer: Sample Matters
por: Haibe-Kains, Benjamin, et al.
Publicado: (2018)

MM2S: personalized diagnosis of medulloblastoma patients and model systems
por: Gendoo, Deena M.A., et al.
Publicado: (2016)

Assessment of modelling strategies for drug response prediction in cell lines and xenografts
por: Kurilov, Roman, et al.
Publicado: (2020)

Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial
por: Sonnenblick, Amir, et al.
Publicado: (2015)

Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome
por: Venet, David, et al.
Publicado: (2020)

Untangling statistical and biological models to understand network inference: the need for a genomics network ontology
por: Emmert-Streib, Frank, et al.
Publicado: (2014)

Gene regulatory networks and their applications: understanding biological and medical problems in terms of networks
por: Emmert-Streib, Frank, et al.
Publicado: (2014)

The impact of violating the independence assumption in meta-analysis on biomarker discovery
por: Abbas-Aghababazadeh, Farnoosh, et al.
Publicado: (2023)

Improving Infinium MethylationEPIC data processing: re-annotation of enhancers and long noncoding RNA genes and benchmarking of normalization methods
por: Bizet, Martin, et al.
Publicado: (2022)

Minimising Immunohistochemical False Negative ER Classification Using a Complementary 23 Gene Expression Signature of ER Status
por: Li, Qiyuan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_pdngt2g4349fjd6n8et982haga